Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-Africa secures 400 million more COVID-19 vaccine doses

Thu, 28th Jan 2021 12:27

* African Union secures 400 mln more AstraZeneca doses

* Health bodies hope to cover 60% of Africans in 2-3 years

* Tanzania's president says God and steam will protect
people
(Recasts, with details about vaccines)

By George Obulutsa

NAIROBI, Jan 28 (Reuters) - The African Union (AU) has
secured another 400 million doses of the AstraZeneca
COVID-19 vaccine, a regional health leader said on Thursday, in
a push to immunize 60% of the continent's population over three
years.

As richer nations race ahead with mass immunisation
campaigns, Africa is scrambling to obtain supplies for its 1.3
billion people. Only a handful of African nations have begun
giving doses.

John Nkengasong, director of the AU's disease control and
prevention body, told an online briefing that in addition to 270
million doses previously secured, the bloc would get 400 million
shots from the Serum Institute of India (SII) - all
AstraZeneca/Oxford University shots.

A spokesman for the SII declined comment.

The AstraZeneca vaccine is the cheapest option and one of
the best-suited to African health systems as it does not require
storage at ultra-low temperatures like the vaccine from Pfizer
and German partner BioNTech.

Separately from the AU's efforts, Africa is to receive about
600 million vaccine doses this year via the COVAX facility
co-led by the World Health Organization (WHO).

Health authorities hope to vaccinate about 30-35% of
Africans this year, rising to 60% in two to three years. The AU
has said vaccines secured by its vaccine task team will be
allocated according to population.

Though COVID-19 has not hit Africa as badly as some experts
had feared it would, wealth disparities, logistical difficulties
and "vaccine nationalism" by developed nations may put the
world's poorest continent at a disadvantage.

Africa has reported 3.5 million infections and 88,000
deaths, according to a Reuters tally. That is fewer fatalities
than individual nations the United States, Brazil, India, Mexico
and Britain.

OUTLIER TANZANIA

In an implicit rebuke to Tanzanian President John Magufuli,
who has discouraged mask-wearing and social distancing,
discontinued data publication and called vaccines a malign
foreign plot, WHO Africa director Matshidiso Moeti urged
Tanzania to implement such measures, prepare vaccinations and
share data.

"Africa is at a crossroads and all Africans must double down
on preventive measures," she told an online news conference on
Thursday, saying WHO officials were in touch with Tanzanian
officials. "Science shows that vaccines work."

Magufuli's government has published no coronavirus data
since May 8, when the country had 509 cases and 21 deaths.

On Wednesday, he said, without evidence, that vaccines were
a foreign plot to spread illness and steal Africa's wealth. He
urged Tanzanians instead to trust God and use alternative
remedies such as steam inhalation.

"We in Tanzania managed to stay for a year without corona.
Even here, no one has put on a mask. Our God is beyond Satan and
Satan will always fail using different diseases," he said in a
speech in his western home area.

Nkengasong said the Africa CDC was exploring obtaining more
vaccines from China, Russia and Cuba, and would work with any
partner whose vaccine was safe and effective.
(Reporting by George Obulutsa, Nairobi newsroom and Alexander
Winning;
Writing by Andrew Cawthorne
Editing by Alex Richardson and Frances Kerry)

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.